ATE484587T1 - Ldcam genannte moleküle - Google Patents

Ldcam genannte moleküle

Info

Publication number
ATE484587T1
ATE484587T1 AT99942039T AT99942039T ATE484587T1 AT E484587 T1 ATE484587 T1 AT E484587T1 AT 99942039 T AT99942039 T AT 99942039T AT 99942039 T AT99942039 T AT 99942039T AT E484587 T1 ATE484587 T1 AT E484587T1
Authority
AT
Austria
Prior art keywords
ldcam
molecules called
polypeptides
purified
compositions
Prior art date
Application number
AT99942039T
Other languages
English (en)
Inventor
Peter Baum
William Fanslow
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE484587T1 publication Critical patent/ATE484587T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Vending Machines For Individual Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT99942039T 1998-08-07 1999-08-05 Ldcam genannte moleküle ATE484587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9567298P 1998-08-07 1998-08-07
PCT/US1999/017905 WO2000008158A2 (en) 1998-08-07 1999-08-05 Molecules designated ldcam

Publications (1)

Publication Number Publication Date
ATE484587T1 true ATE484587T1 (de) 2010-10-15

Family

ID=22253083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942039T ATE484587T1 (de) 1998-08-07 1999-08-05 Ldcam genannte moleküle

Country Status (11)

Country Link
US (5) US7402655B2 (de)
EP (1) EP1102848B1 (de)
JP (1) JP4426724B2 (de)
AT (1) ATE484587T1 (de)
AU (1) AU776825B2 (de)
CA (1) CA2337100C (de)
DE (1) DE69942861D1 (de)
ES (1) ES2353637T3 (de)
IL (3) IL140937A0 (de)
NZ (1) NZ510356A (de)
WO (1) WO2000008158A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776825B2 (en) * 1998-08-07 2004-09-23 Immunex Corporation Molecules designated LDCAM
WO2000032633A1 (en) * 1998-12-02 2000-06-08 Icos Corporation Novel adhesion molecule and methods of use
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (de) * 1999-07-08 2005-03-16 Research Association for Biotechnology Sekretorische- oder Membranproteine
AU8026500A (en) * 1999-10-18 2001-04-30 Texas Biotechnology Corporation Polynucleotides encoding human and murine adhesion proteins (bigr)
EP1339871B1 (de) * 2000-08-15 2008-10-15 The Johns Hopkins University School Of Medicine Diagnose und behandlung von tumor-suppressor assoziierten krankheiten
UY27304A1 (es) * 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20050232896A1 (en) * 2001-10-04 2005-10-20 Herbert Schwarz Cd137 as a proliferation factor for hematopoietic stem cells
EP1536821A4 (de) * 2002-06-17 2009-09-09 Wyeth Corp Hemmung der t-zellaktivierung durch butyrophilin 4 oder b7-l1
EP2133362B1 (de) * 2003-07-25 2012-04-18 Amgen, Inc Verfahren bezüglich LDCAM und CRTAM
EP2069793B9 (de) * 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identifizierung von mit hepatozellulärem karzinom, glioblastom und lungenkrebs assoziiertem protein
US8737317B2 (en) * 2008-05-13 2014-05-27 Qualcomm Incorporated Autonomous carrier selection for femtocells
CN102341412B (zh) 2009-03-05 2018-01-05 梅达雷克斯有限责任公司 特异于cadm1 的全人抗体
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
EP3041863A4 (de) 2013-09-05 2017-08-16 Amgen Inc. Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen
US10156562B2 (en) 2014-05-16 2018-12-18 Amgen Inc. Assay for detecting Th1 and Th2 cell populations
US11978336B2 (en) 2015-07-07 2024-05-07 Ilumi Solutions, Inc. Wireless control device and methods thereof
WO2017007926A1 (en) 2015-07-07 2017-01-12 Ilumi Solutions, Inc. Wireless communication methods
CA3056011A1 (en) 2017-03-14 2018-09-20 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
US12325737B2 (en) 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
BR112022005583A2 (pt) 2019-09-26 2022-09-20 Amgen Inc Métodos para a produção de composições de anticorpos
US20230273126A1 (en) 2020-06-04 2023-08-31 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
KR20230087539A (ko) 2020-10-15 2023-06-16 암젠 인크 항체 생산 방법에서의 상대적인 비결합 글리칸
EP4352094A1 (de) 2021-06-07 2024-04-17 Amgen Inc. Verwendung von fucosidase zur steuerung des afucosylierungsniveaus glykosylierter proteine
US20250076309A1 (en) 2021-10-05 2025-03-06 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
AU2024256160A1 (en) 2023-04-20 2025-10-02 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (en) 2023-08-14 2025-02-20 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
NZ527900A (en) * 1997-12-03 2005-02-25 Genentech Inc PRO361 polypeptides and nucleic acids with homology to mucin and chitinase
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999057132A1 (en) 1998-05-07 1999-11-11 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU776825B2 (en) * 1998-08-07 2004-09-23 Immunex Corporation Molecules designated LDCAM
EP1108042B1 (de) * 1998-08-07 2008-11-26 Immunex Corporation B7l-1 moleküle
EP1124850A4 (de) 1998-10-28 2005-10-19 Human Genome Sciences Inc 12 menschliche sekretierte proteine
AU2474700A (en) 1998-12-01 2000-06-19 Genentech Inc. Secreted amd transmembrane polypeptides and nucleic acids encoding the same
WO2001054477A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
AU755574B2 (en) 1999-06-30 2002-12-19 Sigma-Aldrich Co. Synthetic peptide immunogens and antibodies thereto
AU2001296301A8 (en) 2000-09-26 2009-07-30 Human Genome Sciences Inc Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
NZ510356A (en) 2004-12-24
EP1102848A2 (de) 2001-05-30
IL193886A (en) 2010-12-30
EP1102848B1 (de) 2010-10-13
CA2337100C (en) 2011-09-20
IL193886A0 (en) 2009-05-04
US20090011499A1 (en) 2009-01-08
US20040204568A1 (en) 2004-10-14
WO2000008158A3 (en) 2000-05-11
JP2002523021A (ja) 2002-07-30
US20090155845A1 (en) 2009-06-18
JP4426724B2 (ja) 2010-03-03
US20100215572A1 (en) 2010-08-26
IL140937A (en) 2010-05-31
AU5550399A (en) 2000-02-28
AU776825B2 (en) 2004-09-23
IL140937A0 (en) 2002-02-10
ES2353637T3 (es) 2011-03-03
CA2337100A1 (en) 2000-02-17
US20020168712A1 (en) 2002-11-14
WO2000008158A2 (en) 2000-02-17
DE69942861D1 (de) 2010-11-25
US7741115B2 (en) 2010-06-22
US7659385B2 (en) 2010-02-09
US7402655B2 (en) 2008-07-22

Similar Documents

Publication Publication Date Title
ATE484587T1 (de) Ldcam genannte moleküle
ATE415480T1 (de) B7l-1 moleküle
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DK1015586T3 (da) TIE-receptortyrosinkinaseligandhomologer
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
PT917571E (pt) Gene relacionado com agouti
DK0804558T3 (da) Tripeptidylaminopeptidase
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
SE9801455D0 (sv) New receptor
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ATE408687T1 (de) Semaphorin polypeptide
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
SE9604439D0 (sv) New receptor
DE69827808D1 (de) Protease-ähnliches protein
HK1031229A (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties